INCREASED LIPID FLUIDITY OF ERYTHROCYTE-MEMBRANE AND PLATELET IN TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIA

被引:0
|
作者
MULLER, S
DONNER, M
DROESCH, S
DROUIN, P
STOLTZ, JF
机构
[1] INSERM,U284,F-54511 VANDOEUVRE NANCY,FRANCE
[2] CHU NANCY,HOP JEANNE DARC,SERV MED G,F-54201 DOMMARTIN TOUL,FRANCE
来源
CLINICAL HEMORHEOLOGY | 1987年 / 7卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:442 / 442
页数:1
相关论文
共 50 条
  • [31] FENOFIBRATE IN TYPE-IV AND TYPE-V HYPERLIPOPROTEINEMIA
    SEIDEHAMEL, RJ
    [J]. CARDIOLOGY, 1989, 76 : 23 - 32
  • [32] ERYTHROCYTE-MEMBRANE FLUIDITY IN TYPE-1 DIABETES-MELLITUS
    HILL, MA
    COURT, JM
    [J]. AUSTRALIAN PAEDIATRIC JOURNAL, 1982, 18 (03): : 227 - 227
  • [33] ALTERATION OF ERYTHROCYTE-MEMBRANE LIPID FLUIDITY IN HUMAN OBESITY
    BEGUINOT, F
    TRAMONTANO, D
    DUILIO, C
    FORMISANO, S
    BEGUINOT, L
    MATTIOLI, P
    MANCINI, M
    ALOJ, SM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (06): : 1226 - 1230
  • [34] ERYTHROCYTE-MEMBRANE FLUIDITY IN TYPE-1 DIABETES-MELLITUS
    HILL, MA
    COURT, JM
    [J]. PATHOLOGY, 1983, 15 (04) : 449 - 451
  • [35] THERAPEUTIC EFFECTS OF BEZAFIBRATE AND GEMFIBROZIL IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    KREMER, P
    MAROWSKI, C
    JONES, C
    ACACIA, E
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 (05) : 293 - 303
  • [36] ACTIVITY OF BINIFIBRATE (WAC 104-BINIWAS) IN PATIENTS WITH TYPE-IIA, TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIAS
    DALMAU, M
    MONASTERIO, J
    NOGUES, R
    PICO, M
    BRUSEGHINI, L
    DIEZ, S
    FREIXES, J
    ANDREOLI, R
    [J]. JOURNAL DE PHARMACOLOGIE, 1983, 14 (04) : 708 - 708
  • [37] EFFECT OF COLESTIPOL AND CLOFIBRATE, SINGLY AND IN COMBINATION, ON PLASMA-LIPID AND LIPOPROTEINS IN TYPE-IIB HYPERLIPOPROTEINEMIA
    HUNNINGHAKE, DB
    BELL, C
    OLSON, L
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (06): : 610 - 615
  • [38] APOLIPOPROTEIN-E ALLELE FREQUENCIES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS WITH HYPERTRIGLYCERIDEMIA (TYPE-IIB, TYPE-III, TYPE-IV, AND TYPE-V HYPERLIPOPROTEINEMIA)
    ETO, M
    WATANABE, K
    MAKINO, I
    ISHII, K
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (08): : 776 - 780
  • [39] A LIPOPROTEIN STRUCTURAL ABNORMALITY IN TYPE-IV HYPERLIPOPROTEINEMIA
    FISHER, WR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (06): : A29 - &
  • [40] SERUM IMMUNOREACTIVE TRYPSIN IN TYPE-IV HYPERLIPOPROTEINEMIA
    STERNINI, C
    FERRI, GL
    TOMASSETTI, P
    BONORA, G
    BOTTI, PL
    VEZZADINI, P
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1980, 15 : 45 - 48